CXCR4 antagonist (IC50 = 126 nM). Displays anti-HIV activity in assays using NL4-3 and IIIB strains (EC50 = 21 nM for both strains).
|Sequence||XGYRR (Modifications: Cyclic peptide, X = 2-Nal, Tyr-3 = D-Tyr]|
|Storage||Store at -20°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
|Solubility||Soluble to 2 mg/ml in water|
References are publications that support the biological activity of the product.
Tamamura et al (2005) Stereoselective synthesis of [L-Arg-L/D-3-(2-naphthyl)alanine]-type (E)-alkene dipeptide isosteres and its application to the synthesis and biological evaluation of pseudopeptide analogues of the CXCR4 antagonist FC131 J.Med.Chem. 48 380 PMID: 15658852
Inokuchi et al (2011) Potent CXCR4 antagonists containing amidine type peptide bond isosteres. ACS Med.Chem.Lett. 2 477
If you know of a relevant reference for FC 131, please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: FC 131, FC 131 supplier, FC131, cxcr4, antagonists, chemokines, receptors, anti-HIV, Antivirals, Chemokine, CXC, Receptors, 4320, Tocris Bioscience
Citations for FC 131
Citations are publications that use Tocris products.
Currently there are no citations for FC 131. Do you know of a great paper that uses FC 131 from Tocris? Please let us know.
Reviews for FC 131
There are currently no reviews for this product. Be the first to review FC 131 and earn rewards!
Have you used FC 131?
Submit a review and receive an Amazon gift card.
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Literature in this Area
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* or download your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.